FDA New Electronic Data Capture Guidance - What is the Impact on Inspectional Record Requirements

  • Check with publisher
  • Published date: November 3, 2017
    • Fremont, California, United States

Training Options Duration: 60 Minutes
Monday, December 4, 2017 | 10:00 AM PDT | 01:00 PM EDT

Overview: FDA 7348.811 section 1 states, "Regardless of the type of system used by the

clinical site, the regulatory requirements for clinical data do not change whether clinical

data are captured on paper, electronically, or using a hybrid system." What type of system is

best for your program and investigator capabilities? The wrong choice yields inspectional non

compliance.

The right choice of electronic data capture, direct data entry, and data management depends

on a sponsor assessment of the systems and procedures at the investigator site as compliant

with FDA inspectional requirements. Additional source documentation procedures (origination,

authorization, and signature) are required at the investigator site to address the electronic

data capture process. It is these three FDA mandated inspectional criteria, applicable to

every electronic data element, that generate most of the significant inspectional

noncompliant findings. Some data elements are more likely to be associated with the findings

of noncompliance than others. It is in fact difficult to determine which data requires or

does not require original source documentation and what defines "original source

documentation".

Why should you Attend: Investigators commonly assume that the new guidance and regulations

reduce the need for source documentation in clinical trials. In fact, there are new

procedural documents relevant to the electronic source documents and direct data entry that

are required to comply with the current inspectional standards and the final guidance.

Sponsor due diligence in choosing, training, and monitoring investigator sites to enable the

use of compliant electronic data capture is required.

Basic knowledge of part 11 and GCP requirements will be helpful in attending this advanced

webinar. The focus will be on the additional FDA inspectional requirements for electronic

data capture, and the impact of using electronic data capture on the seven FDA inspectional

priority objectives.

Areas Covered in the Session:

FDA definitions for data elements
FDA definitions of source data and types of electronic source data systems
The requirement for original source data to support every data element
The requirements for electronic data-origination, authorization, signatures and data tracking
What types of electronic data elements pose noncompliance challenges
Preventing non compliance by sponsor due diligence at investigator site
Participant input and questions

Who Will Benefit:
Clinical Research Coordinators and Investigators
Medical Record Personnel
Clinical CRA Monitors
Clinical Program Managers
Clinical Quality Assurance Auditors

Speaker Profile
Sarah Fowler-Dixon, PhD, CIP is Education Specialist and instructor with Washington

University School of Medicine. She has developed a comprehensive education program for human

subject research which has served as a model for other institutions. She crafted budgets,

policies, procedures, reporting, and training for the new program. She has initiated the

planning, development, authorship and implementation of many human subjects research

policies, practices, guidelines, submission and reviewer forms often working with state and

federal authorities.

She has provided consultation regarding ethical, federal, state, and institutional

requirements for faculty and staff both in the design and execution of their projects and

teaches research ethics and regulatory affairs and the fundamentals of research management to

graduate and undergraduate students. More recently, she lead a task force in the development

of the Community Engaged Research Program at Washington University. Dr. Fowler-Dixon has

simultaneously served as an Independent Consultant, providing expertise and creating

supplemental educational materials, including a copyrighted workbook.

Prior to joining Washington University, Dr. Fowler-Dixon was the Educational Development and

Learning Specialist for Saint Louis University serving on various committees to improve

research, procedures, community outreach, and retention.

Price - $139
Contact Info:
Netzealous LLC -MentorHealth
Phone No: 1-800-385-1607
Fax: 302-288-6884
Email: support@mentorhealth.com
Website: http://www.mentorhealth.com/
Webinar Sponsorship: https://www.mentorhealth.com/control/webinar-sponsorship/

Result 0 votes
Roger Steven
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 2nd Annual Advances in Transgenic Technology USA Congress

    2nd Annual Advances in Transgenic Technology USA Congress

    Life Sciences Boston (Massachusetts) November 2, 2017 Check with publisher

    Oxford Global Conferences are proud to present our 2nd Annual Advances in Transgenic Technology USA Congress, 10-11 May 2018, Boston, USA with our co-located 2nd Annual Genome Editing USA Congress and Synthetic Biology USA Congress. Across the two da...

  • 4th Biologics & Biosimilars Congress

    4th Biologics & Biosimilars Congress

    Life Sciences Berlin (Berlin) September 5, 2017 Check with publisher

    This internationally respected congress is the networking meeting for those working in all areas of protein, antibody & biosimilar research. Executive panels and roundtables will foster discussion on the direction of the field, and the approaches...

  • The 6th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

    The 6th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

    Life Sciences Tel Aviv (Israel ) June 29, 2017 Check with publisher

    Over the years, our CODHy congress has provided an exclusive platform for excellent academic debates, providing a forum for international experts in the field of Diabetes, Obesity and Hypertension to discuss and compare data. This unique congress for...